Endo Pharmacauticals has discontinued Collagenase Clostridium Histolyticum (CCH) injection
by andromedical Andropenis® penis extender increases Penis Length
Endo Pharmacauticals has
discontinued Collagenase Clostridium Histolyticum (CCH) injection in Australia
and Asia, and plans to do the same to whole Europe by the end of 2019.
The American laboratory has decided to withdraw it for
economic reasons. As a result, the drug is no longer available except in
the US and Canada. Now the only treatment options for Peyronie´s
disease are surgery or Penile Traction Device (alone or combined with PRP), in
the rest of the world. See official letter
letter is to inform you that the company will discontinue the
commercialisation of X.... by the end of 2019.
X..... is a product owned by E.....’). Currently,
X.... is commercialised in the
EU and other European and Middle Eastern countries by the company We have agreed to terminate the cooperation agreement for
X.... effective December 31, 2019. The decision to withdraw is not
based on safety or efficacy concerns.
the company are committed to managing the de-registration of X.... from
the territories in an ethical and transparent manner and it will process the withdrawal of the EU Marketing Authorisation, which
will be effective from 1 March, 2020.
be assured that the wellbeing of patients during the discontinuation
process is of paramount importance and we are committed to
the safety and comfort of all patients during the process of
transition to other therapies. We want to emphasize that, subject to
product availability from our supplier, Sobi is committed to
providing X...... up until the end of 2019.
would like to thank you for your interest in X...... over the years
and deeply regret any inconvenience this may cause you.
you have any questions or concerns, please do not hesitate to contact
us at your convenience.
de-registration, all enquiries, questions or requests for Named
Patient Use of X..... must be referred directly
Business Unit Director
Created on Dec 3rd 2019 07:26. Viewed 398 times.